Justo Aznar Lucea-rekin lankidetzan egindako argitalpenak (4)

1999

  1. Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause - Influence of Hormone Replacement Therapy

    Thrombosis and Haemostasis, Vol. 81, Núm. 1, pp. 104-110

  2. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease. Influence of hormone replacement therapy

    Thrombosis and Haemostasis, Vol. 81, Núm. 4, pp. 516-521

1998

  1. Lipoprotein(a) [Lp(a)] levels and isoforms and fibrinolytic activity in postmenopause. Influence of hormone replacement therapy (HRT)

    Fibrinolysis and Proteolysis, Vol. 12, Núm. SUPPL. 1, pp. 41

1995

  1. The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status

    American Journal of Obstetrics and Gynecology, Vol. 173, Núm. 6, pp. 1849-1854